Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Bristol Myers Squibb Cash on Hand 2010-2025 | BMY

Bristol Myers Squibb cash on hand from 2010 to 2025. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
  • Bristol Myers Squibb cash on hand for the quarter ending March 31, 2025 was $11.782B, a 21.84% increase year-over-year.
  • Bristol Myers Squibb cash on hand for 2024 was $10.859B, a 11.57% decline from 2023.
  • Bristol Myers Squibb cash on hand for 2023 was $12.28B, a 32.71% increase from 2022.
  • Bristol Myers Squibb cash on hand for 2022 was $9.253B, a 45.46% decline from 2021.
  
Bristol Myers Squibb Annual Cash on Hand
(Millions of US $)
2024 $10,859
2023 $12,280
2022 $9,253
2021 $16,966
2020 $15,831
2019 $15,393
2018 $8,759
2017 $6,812
2016 $6,350
2015 $4,270
2014 $7,435
2013 $4,525
2012 $2,829
2011 $8,733
2010 $7,301
2009 $8,514
Bristol Myers Squibb Quarterly Cash on Hand
(Millions of US $)
2025-03-31 $11,782
2024-12-31 $10,859
2024-09-30 $8,094
2024-06-30 $6,653
2024-03-31 $9,670
2023-12-31 $12,280
2023-09-30 $7,685
2023-06-30 $8,730
2023-03-31 $9,269
2022-12-31 $9,253
2022-09-30 $9,027
2022-06-30 $13,228
2022-03-31 $14,968
2021-12-31 $16,966
2021-09-30 $15,663
2021-06-30 $12,970
2021-03-31 $12,930
2020-12-31 $15,831
2020-09-30 $21,155
2020-06-30 $21,658
2020-03-31 $18,322
2019-12-31 $15,393
2019-09-30 $32,542
2019-06-30 $29,357
2019-03-31 $8,764
2018-12-31 $8,759
2018-09-30 $6,830
2018-06-30 $6,075
2018-03-31 $6,770
2017-12-31 $6,812
2017-09-30 $7,122
2017-06-30 $6,505
2017-03-31 $6,109
2016-12-31 $6,350
2016-09-30 $5,560
2016-06-30 $4,651
2016-03-31 $4,307
2015-12-31 $4,270
2015-09-30 $5,413
2015-06-30 $5,476
2015-03-31 $7,607
2014-12-31 $7,435
2014-09-30 $7,221
2014-06-30 $7,175
2014-03-31 $7,059
2013-12-31 $4,525
2013-09-30 $2,722
2013-06-30 $2,799
2013-03-31 $2,533
2012-12-31 $2,829
2012-09-30 $2,930
2012-06-30 $5,037
2012-03-31 $5,029
2011-12-31 $8,733
2011-09-30 $8,193
2011-06-30 $7,670
2011-03-31 $6,793
2010-12-31 $7,301
2010-09-30 $8,359
2010-06-30 $7,454
2010-03-31 $6,776
2009-12-31 $8,514
2009-09-30 $6,669
2009-06-30 $8,120
2009-03-31 $8,920
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $97.379B $48.300B
Bristol-Myers Squibb is a one of the leading global specialty biopharmaceutical companies focused on the development of treatments targeting serious diseases like cancer, inflammatory, immunologic, cardiovascular or fibrotic diseases. Backed by its blockbuster immuno-oncology drug, Opdivo, Bristol-Myers has a strong oncology portfolio, comprising other drugs like Revlimid, Pomalyst, Sprycel, Yervoy and Empliciti. It also has important immunology and cardiovascular drugs like Orencia and Eliquis. It's experiencing growth in both the Eliquis brand and the market, while also advancing its Factor XIa inhibitor program. After the sale of the global Diabetes business to AstraZeneca and the discontinuation of discovery research efforts in virology, it's focusing solely on research in core therapeutic areas like oncology, immuno-oncology, immunoscience, cardiovascular, fibrosis and genetically defined diseases. It acquried Celgene Corporation and MyoKardia. It received regulatory approvals for Reblozyl and Inrebic.
Stock Name Country Market Cap PE Ratio
AstraZeneca (AZN) United Kingdom $219.788B 16.41
Amgen (AMGN) United States $152.461B 13.66
Gilead Sciences (GILD) United States $138.213B 14.35
Vertex Pharmaceuticals (VRTX) United States $114.811B 0.00
GSK (GSK) United Kingdom $82.529B 9.80
CSL (CSLLY) Australia $77.251B 0.00
Regeneron Pharmaceuticals (REGN) United States $65.361B 15.86
Alnylam Pharmaceuticals (ALNY) United States $38.191B 0.00
Argenex SE (ARGX) Netherlands $35.473B 96.82
BeiGene (ONC) Cayman Islands $24.482B 0.00
BioNTech SE (BNTX) Germany $24.099B 0.00
Biogen (BIIB) United States $19.452B 8.39
Royalty Pharma (RPRX) United States $18.352B 7.75
Genmab (GNMSF) Denmark $13.859B 14.17
Genmab (GMAB) Denmark $13.670B 15.34
Illumina (ILMN) United States $13.342B 25.31
Incyte (INCY) United States $12.783B 97.12
Insmed (INSM) United States $12.606B 0.00
Exelixis (EXEL) United States $11.617B 19.72
BioMarin Pharmaceutical (BMRN) United States $11.228B 18.24
Exact Sciences (EXAS) United States $10.869B 0.00
Swedish Orphan Biovitrum (BIOVF) Sweden $10.783B 27.54
Moderna (MRNA) United States $10.415B 0.00
QIAGEN (QGEN) Netherlands $10.003B 19.46
Ascendis Pharma (ASND) Denmark $9.973B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $9.642B 0.00
Roivant Sciences (ROIV) United Kingdom $8.063B 0.00
Bio-Techne Corp (TECH) United States $7.577B 28.26
Revolution Medicines (RVMD) United States $7.280B 0.00
Repligen (RGEN) United States $6.872B 76.93
Bio-Rad Laboratories (BIO.B) United States $6.805B 23.68
Halozyme Therapeutics (HALO) United States $6.744B 12.91
Jazz Pharmaceuticals (JAZZ) Ireland $6.675B 6.43
Blueprint Medicines (BPMC) United States $6.656B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $6.597B 0.00
TG Therapeutics (TGTX) United States $5.669B 148.79
Telix Pharmaceuticals (TLX) Australia $5.553B 0.00
Nuvalent (NUVL) United States $5.368B 0.00
Legend Biotech (LEGN) United States $5.324B 0.00
Axsome Therapeutics (AXSM) United States $5.152B 0.00
Alkermes (ALKS) Ireland $4.988B 13.39
Zealand Pharma (ZLDPF) Denmark $4.803B 0.00
Guardant Health (GH) United States $4.776B 0.00
ADMA Biologics Inc (ADMA) United States $4.720B 35.30
Vaxcyte (PCVX) United States $4.231B 0.00
Rhythm Pharmaceuticals (RYTM) United States $3.937B 0.00
PTC Therapeutics (PTCT) United States $3.875B 6.74
Merus (MRUS) Netherlands $3.832B 0.00
Akero Therapeutics (AKRO) United States $3.829B 0.00
Avidity Biosciences (RNA) United States $3.820B 0.00
Sarepta Therapeutics (SRPT) United States $3.794B 0.00
Cytokinetics (CYTK) United States $3.740B 0.00
ACADIA Pharmaceuticals (ACAD) United States $3.731B 32.78
Krystal Biotech (KRYS) United States $3.630B 27.98
SpringWorks Therapeutics (SWTX) United States $3.517B 0.00
Arcellx (ACLX) United States $3.509B 0.00
Zai Lab (ZLAB) China $3.454B 0.00
Alvotech (ALVO) Luxembourg $3.359B 19.21
Ultragenyx Pharmaceutical (RARE) United States $3.312B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.176B 0.00
Viking Therapeutics (VKTX) United States $3.163B 0.00
Protagonist Therapeutics (PTGX) United States $2.949B 63.44
Metsera (MTSR) United States $2.898B 0.00
Scholar Rock Holding (SRRK) United States $2.833B 0.00
Immunovant (IMVT) United States $2.529B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $2.494B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.416B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.323B 0.00
ImmunityBio (IBRX) United States $2.295B 0.00
Xenon Pharmaceuticals (XENE) Canada $2.228B 0.00
Ascentage Pharma Group - (AAPG) China $2.208B 0.00
Apellis Pharmaceuticals (APLS) United States $2.188B 0.00
Mirum Pharmaceuticals (MIRM) United States $2.180B 0.00
NovoCure (NVCR) Jersey $2.163B 0.00
Belite Bio (BLTE) United States $2.090B 0.00
Vericel (VCEL) United States $2.082B 1378.33
Bavarian Nordic (BVNRY) Denmark $2.058B 10.88
CG Oncology (CGON) United States $1.999B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $1.983B 0.00
Kymera Therapeutics (KYMR) United States $1.970B 0.00
Denali Therapeutics (DNLI) United States $1.967B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.955B 13.00
Ligand Pharmaceuticals (LGND) United States $1.947B 0.00
Amicus Therapeutics (FOLD) United States $1.912B 207.00
Certara (CERT) United States $1.849B 34.54
Agios Pharmaceuticals (AGIO) United States $1.844B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.825B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.760B 0.00
IDEAYA Biosciences (IDYA) United States $1.756B 0.00
Apogee Therapeutics (APGE) United States $1.735B 0.00
Twist Bioscience (TWST) United States $1.731B 0.00
Beam Therapeutics (BEAM) United States $1.641B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.629B 0.00
Disc Medicine (IRON) United States $1.623B 0.00
Edgewise Therapeutics (EWTX) United States $1.533B 0.00
Biohaven (BHVN) United States $1.505B 0.00
GRAIL (GRAL) United States $1.479B 0.00
89BIO (ETNB) United States $1.432B 0.00
Janux Therapeutics (JANX) United States $1.423B 0.00
Adaptive Biotechnologies (ADPT) United States $1.414B 0.00
Travere Therapeutics (TVTX) United States $1.366B 0.00
Mesoblast (MESO) Australia $1.365B 0.00
BGM Group (BGM) China $1.354B 0.00
Celldex Therapeutics (CLDX) United States $1.317B 0.00
Structure Therapeutics (GPCR) United States $1.286B 0.00
Liquidia Technologies (LQDA) United States $1.282B 0.00
Vera Therapeutics (VERA) United States $1.271B 0.00
ANI Pharmaceuticals (ANIP) United States $1.262B 13.00
MannKind (MNKD) United States $1.252B 25.75
Pacira BioSciences (PCRX) United States $1.200B 11.42
Dynavax Technologies (DVAX) United States $1.172B 69.71
Novavax (NVAX) United States $1.165B 2.71
Viridian Therapeutics (VRDN) United States $1.140B 0.00
Anbio Biotechnology (NNNN) Germany $1.115B 0.00
CureVac (CVAC) Germany $1.039B 5.03
Mineralys Therapeutics (MLYS) United States $1.021B 0.00
Arcus Biosciences (RCUS) United States $1.007B 0.00
MiMedx (MDXG) United States $0.967B 23.39
WAVE Life Sciences (WVE) Singapore $0.962B 0.00
NeoGenomics (NEO) United States $0.948B 0.00
Geron (GERN) United States $0.943B 0.00
Spyre Therapeutics (SYRE) United States $0.937B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.914B 0.00
Gyre Therapeutics (GYRE) United States $0.887B 236.50
Pharvaris (PHVS) Netherlands $0.874B 0.00
Niagen Bioscience (NAGE) United States $0.852B 120.22
Oculis Holding AG (OCS) Switzerland $0.851B 0.00
LENZ Therapeutics (LENZ) United States $0.831B 0.00
CorMedix Inc (CRMD) United States $0.829B 55.54
UniQure (QURE) Netherlands $0.816B 0.00
Nurix Therapeutics (NRIX) United States $0.811B 0.00
Zymeworks (ZYME) United States $0.790B 0.00
Praxis Precision Medicines (PRAX) United States $0.783B 0.00
Immunome (IMNM) United States $0.779B 0.00
Intellia Therapeutics (NTLA) United States $0.772B 0.00
Nuvation Bio (NUVB) United States $0.769B 0.00
Replimune (REPL) United States $0.722B 0.00
Pharming Group (PHAR) Netherlands $0.721B 0.00
ArriVent BioPharma (AVBP) United States $0.718B 0.00
Vir Biotechnology (VIR) United States $0.717B 0.00
Pharming Group (PHGUF) Netherlands $0.671B 0.00
AnaptysBio (ANAB) United States $0.663B 0.00
Immatics (IMTX) Germany $0.661B 0.00
Arbutus Biopharma (ABUS) United States $0.659B 0.00
Day One Biopharmaceuticals (DAWN) United States $0.657B 0.00
Anavex Life Sciences (AVXL) United States $0.651B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Trevi Therapeutics (TRVI) United States $0.635B 0.00
GH Research (GHRS) Ireland $0.629B 0.00
Cogent Biosciences (COGT) United States $0.627B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.626B 0.00
Sionna Therapeutics (SION) United States $0.623B 0.00
Iovance Biotherapeutics (IOVA) United States $0.611B 0.00
AbCellera Biologics (ABCL) Canada $0.609B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.603B 0.00
Dianthus Therapeutics (DNTH) United States $0.574B 0.00
Keros Therapeutics (KROS) United States $0.569B 0.00
Oric Pharmaceuticals (ORIC) United States $0.567B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.549B 0.00
Arvinas (ARVN) United States $0.547B 0.00
Maze Therapeutics (MAZE) United States $0.533B 0.00
Stoke Therapeutics (STOK) United States $0.531B 12.32
Opthea (OPT) Australia $0.525B 0.00
Bicara Therapeutics (BCAX) United States $0.515B 0.00
Cullinan Therapeutics (CGEM) United States $0.512B 0.00
Sana Biotechnology (SANA) United States $0.512B 0.00
Eton Pharmaceuticals (ETON) United States $0.507B 0.00
Kura Oncology (KURA) United States $0.504B 0.00
Upstream Bio (UPB) United States $0.503B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.496B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.494B 0.00
Tyra Biosciences (TYRA) United States $0.491B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.466B 0.00
Castle Biosciences (CSTL) United States $0.461B 31.27
REGENXBIO (RGNX) United States $0.450B 0.00
PureTech Health (PRTC) United States $0.441B 0.00
Septerna (SEPN) United States $0.439B 0.00
MeiraGTx Holdings (MGTX) United States $0.431B 0.00
Humacyte (HUMA) United States $0.430B 0.00
Verastem (VSTM) United States $0.427B 0.00
MBX Biosciences (MBX) United States $0.425B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.424B 0.00
Zenas BioPharma (ZBIO) United States $0.418B 0.00
Tectonic Therapeutic (TECX) United States $0.418B 0.00
Erasca (ERAS) United States $0.411B 0.00
Precigen (PGEN) United States $0.410B 0.00
Celcuity (CELC) United States $0.410B 0.00
Sage Therapeutics (SAGE) United States $0.408B 0.00
Benitec Biopharma (BNTC) United States $0.399B 0.00
Kamada (KMDA) Israel $0.395B 23.69
Northwest Biotherapeutics (NWBO) United States $0.388B 0.00
Zhengye Biotechnology Holding (ZYBT) China $0.386B 0.00
ITeos Therapeutics (ITOS) United States $0.384B 0.00
Myriad Genetics (MYGN) United States $0.383B 0.00
Fulcrum Therapeutics (FULC) United States $0.382B 0.00
Abivax SA (ABVX) France $0.382B 0.00
ATyr Pharma (ATYR) United States $0.379B 0.00
Fortrea Holdings (FTRE) United States $0.378B 10.45
Checkpoint Therapeutics (CKPT) United States $0.371B 0.00
Vigil Neuroscience (VIGL) United States $0.368B 0.00
Olema Pharmaceuticals (OLMA) United States $0.363B 0.00
Rezolute (RZLT) United States $0.355B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.351B 0.00
Emergent Biosolutions (EBS) United States $0.351B 0.00
Absci (ABSI) United States $0.350B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.345B 0.00
Cytek Biosciences (CTKB) United States $0.328B 0.00
Inventiva S.A (IVA) France $0.324B 0.00
Alpha Teknova (TKNO) United States $0.316B 0.00
Abeona Therapeutics (ABEO) United States $0.315B 0.00
Rapport Therapeutics (RAPP) United States $0.311B 0.00
Aura Biosciences (AURA) United States $0.306B 0.00
XOMA Royalty (XOMA) United States $0.305B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.301B 0.00
Entrada Therapeutics (TRDA) United States $0.300B 9.75
Compass Therapeutics (CMPX) United States $0.293B 0.00
Candel Therapeutics (CADL) United States $0.293B 0.00
Prima BioMed (IMMP) Australia $0.288B 0.00
Rocket Pharmaceuticals (RCKT) United States $0.280B 0.00
Tvardi Therapeutics (TVRD) United States $0.280B 0.00
Astria Therapeutics (ATXS) United States $0.279B 0.00
Cidara Therapeutics (CDTX) United States $0.276B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.275B 0.00
Palvella Therapeutics (PVLA) United States $0.274B 0.00
Terns Pharmaceuticals (TERN) United States $0.271B 0.00
Neurogene (NGNE) United States $0.267B 0.00
2seventy Bio (TSVT) United States $0.266B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.260B 52.88
Cartesian Therapeutics (RNAC) United States $0.260B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.259B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.259B 0.00
Allogene Therapeutics (ALLO) United States $0.258B 0.00
Gossamer Bio (GOSS) United States $0.257B 0.00
Solid Biosciences (SLDB) United States $0.256B 0.00
Inozyme Pharma (INZY) United States $0.255B 0.00
Lifecore Biomedical (LFCR) United States $0.254B 0.00
Prothena (PRTA) Ireland $0.253B 0.00
Tango Therapeutics (TNGX) United States $0.253B 0.00
Atea Pharmaceuticals (AVIR) United States $0.252B 0.00
Semper Paratus Acquisition (TVGN) United States $0.246B 0.00
MaxCyte (MXCT) United States $0.246B 0.00
Ocugen (OCGN) United States $0.244B 0.00
Amarin (AMRN) Ireland $0.242B 0.00
DBV Technologies S.A (DBVT) France $0.241B 0.00
Foghorn Therapeutics (FHTX) United States $0.241B 0.00
Annexon (ANNX) United States $0.239B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.239B 0.00
Third Harmonic Bio (THRD) United States $0.235B 0.00
ACELYRIN, INC (SLRN) United States $0.229B 0.00
Design Therapeutics (DSGN) United States $0.228B 0.00
Adherex Technologies (FENC) United States $0.224B 0.00
Aardvark Therapeutics (AARD) United States $0.223B 0.00
Cardiff Oncology (CRDF) United States $0.222B 0.00
GENFIT S.A (GNFT) France $0.219B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.215B 0.00
Adocia (ADOCY) France $0.213B 0.00
Actuate Therapeutics (ACTU) United States $0.207B 0.00
CytomX Therapeutics (CTMX) United States $0.203B 5.25
Innate Pharma S.A (IPHA) France $0.203B 0.00
EnGene Holdings (ENGN) Canada $0.202B 0.00
Instil Bio (TIL) United States $0.199B 0.00
Inhibrx Biosciences (INBX) United States $0.199B 0.12
Monopar Therapeutics (MNPR) United States $0.198B 0.00
Nuvectis Pharma (NVCT) United States $0.195B 0.00
Codexis (CDXS) United States $0.195B 0.00
CARGO Therapeutics (CRGX) United States $0.195B 0.00
Bright Minds Biosciences (DRUG) United States $0.193B 0.00
Kodiak Sciences (KOD) United States $0.188B 0.00
BioStem Technologies (BSEM) $0.187B 7.63
ScPharmaceuticals (SCPH) United States $0.187B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.185B 0.00
Alumis (ALMS) United States $0.185B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.183B 0.00
Urogen Pharma (URGN) United States $0.183B 0.00
DiaMedica Therapeutics (DMAC) United States $0.180B 0.00
Galena Biopharma (SLS) United States $0.171B 0.00
AC Immune (ACIU) Switzerland $0.170B 0.00
INmune Bio (INMB) United States $0.169B 0.00
Puma Biotechnology (PBYI) United States $0.168B 4.39
Prime Medicine (PRME) United States $0.165B 0.00
Alpha Cognition (ACOG) Canada $0.162B 0.00
Anika Therapeutics (ANIK) United States $0.161B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.161B 0.00
Voyager Therapeutics (VYGR) United States $0.156B 0.00
Editas Medicine (EDIT) United States $0.153B 0.00
Fate Therapeutics (FATE) United States $0.151B 0.00
Molecular Partners AG (MOLN) Switzerland $0.144B 0.00
BioAge Labs (BIOA) United States $0.143B 0.00
Alector (ALEC) United States $0.142B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.141B 0.00
TuHURA Biosciences (HURA) United States $0.139B 0.00
Compugen (CGEN) Israel $0.137B 0.00
Greenwich LifeSciences (GLSI) United States $0.133B 0.00
Ventyx Biosciences (VTYX) United States $0.129B 0.00
Nkarta (NKTX) United States $0.128B 0.00
Black Diamond Therapeutics (BDTX) United States $0.128B 37.50
Rapt Therapeutics (RAPT) United States $0.123B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.122B 0.00
Elicio Therapeutics (ELTX) United States $0.120B 0.00
Theratechnologies (THTX) Canada $0.120B 0.00
Spero Therapeutics (SPRO) United States $0.119B 0.00
EXoZymes (EXOZ) United States $0.116B 0.00
Neumora Therapeutics (NMRA) United States $0.116B 0.00
Kyverna Therapeutics (KYTX) United States $0.114B 0.00
Seer (SEER) United States $0.112B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.108B 0.00
Caribou Biosciences (CRBU) United States $0.108B 0.00
Sagimet Biosciences (SGMT) United States $0.107B 0.00
Sangamo Therapeutics (SGMO) United States $0.107B 0.00
BioHarvest Sciences (BHST) Canada $0.104B 0.00
I-Mab (IMAB) United States $0.103B 0.00
Invivyd (IVVD) United States $0.102B 0.00
Nautilus Biotechnology (NAUT) United States $0.101B 0.00
Cuprina Holdings (Cayman) (CUPR) Singapore $0.100B 0.00
Cabaletta Bio (CABA) United States $0.097B 0.00
C4 Therapeutics (CCCC) United States $0.094B 0.00
HilleVax (HLVX) United States $0.093B 0.00
Coherus BioSciences (CHRS) United States $0.093B 0.00
Genelux (GNLX) United States $0.093B 0.00
Contineum Therapeutics (CTNM) United States $0.092B 0.00
Adagene (ADAG) China $0.092B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.090B 0.00
Coya Therapeutics (COYA) United States $0.089B 0.00
Agenus (AGEN) United States $0.088B 0.00
XBiotech (XBIT) United States $0.087B 0.00
Jasper Therapeutics (JSPR) United States $0.085B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.085B 0.00
Whitehawk Therapeutics (WHWK) United States $0.085B 0.00
Pliant Therapeutics (PLRX) United States $0.084B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.084B 0.00
TScan Therapeutics (TCRX) United States $0.083B 0.00
Entera Bio (ENTX) Israel $0.083B 0.00
Climb Bio (CLYM) United States $0.082B 0.00
23andMe Holding (MEHCQ) United States $0.082B 0.00
Genenta Science S.p.A (GNTA) Italy $0.081B 0.00
Senti Biosciences (SNTI) United States $0.081B 0.00
Cellectis S.A (CLLS) France $0.080B 0.00
IO Biotech (IOBT) Denmark $0.080B 0.00
IGM Biosciences (IGMS) United States $0.080B 0.00
Inovio Pharmaceuticals (INO) United States $0.078B 0.00
Sutro Biopharma (STRO) United States $0.076B 0.00
Adlai Nortye (ANL) Cayman Islands $0.074B 0.00
VistaGen Therapeutics (VTGN) United States $0.074B 0.00
Alto Neuroscience (ANRO) United States $0.073B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.072B 0.00
Tenaya Therapeutics (TNYA) United States $0.072B 0.00
BeyondSpring (BYSI) United States $0.070B 0.00
Zura Bio (ZURA) United States $0.070B 0.00
MediciNova (MNOV) United States $0.070B 0.00
Elutia (ELUT) United States $0.068B 0.00
CervoMed (CRVO) United States $0.068B 0.00
Skye Bioscience (SKYE) United States $0.066B 0.00
Immunic (IMUX) United States $0.065B 0.00
PDS Biotechnology (PDSB) United States $0.064B 0.00
Citius Oncology (CTOR) United States $0.064B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.064B 0.00
OKYO Pharma (OKYO) $0.063B 0.00
Immix Biopharma (IMMX) United States $0.063B 0.00
Seres Therapeutics (MCRB) United States $0.062B 0.00
Akoya Biosciences (AKYA) United States $0.062B 0.00
Exicure (XCUR) United States $0.061B 0.00
Immuneering (IMRX) United States $0.061B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.061B 0.00
Clearside Biomedical (CLSD) United States $0.061B 0.00
Oncobiologics (OTLK) United States $0.060B 0.00
Adicet Bio (ACET) United States $0.060B 0.00
ZIVO Bioscience (ZIVO) United States $0.059B 0.00
Opus Genetics (IRD) United States $0.059B 0.00
Repare Therapeutics (RPTX) Canada $0.059B 0.00
Fortress Biotech (FBIO) United States $0.058B 0.00
Werewolf Therapeutics (HOWL) United States $0.057B 0.00
InflaRx (IFRX) Germany $0.057B 0.00
Ikena Oncology (IKNA) United States $0.057B 0.00
Biomea Fusion (BMEA) United States $0.056B 0.00
Kalaris Therapeutics (KLRS) United States $0.055B 0.00
Forte Biosciences (FBRX) United States $0.055B 0.00
PepGen (PEPG) United States $0.055B 0.00
Celularity (CELU) United States $0.055B 0.00
Precision BioSciences (DTIL) United States $0.055B 0.00
Renovaro (RENB) United States $0.054B 0.00
TELA Bio (TELA) United States $0.054B 0.00
VTv Therapeutics (VTVT) United States $0.052B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.052B 0.00
Shattuck Labs (STTK) United States $0.052B 0.00
Applied Therapeutics (APLT) United States $0.051B 0.00
Artiva Biotherapeutics (ARTV) United States $0.050B 0.00
Xilio Therapeutics (XLO) United States $0.050B 0.00
RenovoRx (RNXT) United States $0.049B 0.00
Medicus Pharma (MDCX) United States $0.049B 0.00
Bluebird Bio (BLUE) United States $0.049B 0.00
Cue Biopharma (CUE) United States $0.049B 0.00
Quince Therapeutics (QNCX) United States $0.047B 0.00
Adverum Biotechnologies (ADVM) United States $0.047B 0.00
Annovis Bio (ANVS) United States $0.047B 0.00
Atara Biotherapeutics (ATRA) United States $0.047B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.044B 0.00
Mersana Therapeutics (MRSN) United States $0.044B 0.00
Connect Biopharma Holdings (CNTB) United States $0.043B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.043B 0.00
Rein Therapeutics (RNTX) United States $0.043B 0.00
CAMP4 Therapeutics (CAMP) United States $0.042B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.042B 0.00
Alterity Therapeutics - (ATHE) Australia $0.041B 0.00
Kronos Bio (KRON) United States $0.041B 0.00
Scilex Holding (SCLX) United States $0.039B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.039B 0.00
Estrella Immunopharma (ESLA) United States $0.037B 0.00
Radiopharm Theranostics - (RADX) Australia $0.037B 0.00
AN2 Therapeutics (ANTX) United States $0.037B 0.00
Pluri (PLUR) Israel $0.036B 0.00
Aligos Therapeutics (ALGS) United States $0.035B 0.00
Imunon (IMNN) United States $0.035B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.035B 0.00
OnKure Therapeutics (OKUR) United States $0.034B 0.00
Quantum Biopharma (QNTM) Canada $0.034B 0.00
Lantern Pharma (LTRN) United States $0.034B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.033B 0.00
Rani Therapeutics Holdings (RANI) United States $0.033B 0.00
Oncolytics Biotech (ONCY) Canada $0.032B 0.00
Dyadic (DYAI) United States $0.031B 0.00
Kezar Life Sciences (KZR) United States $0.030B 0.00
Aspire Biopharma Holdings (ASBP) United States $0.030B 0.00
Allakos (ALLK) United States $0.030B 0.00
Grace Therapeutics (GRCE) Canada $0.029B 0.00
FibroBiologics (FBLG) United States $0.029B 0.00
Passage Bio (PASG) United States $0.028B 0.00
Femasys (FEMY) United States $0.028B 0.00
MiNK Therapeutics (INKT) United States $0.028B 0.00
Cadrenal Therapeutics (CVKD) United States $0.026B 0.00
Boundless Bio (BOLD) United States $0.026B 0.00
Generation Bio (GBIO) United States $0.026B 0.00
Chemomab Therapeutics (CMMB) Israel $0.026B 0.00
Tenax Therapeutics (TENX) United States $0.026B 0.00
Dare Bioscience (DARE) United States $0.025B 0.00
ALX Oncology Holdings (ALXO) United States $0.025B 0.00
KALA BIO (KALA) United States $0.025B 0.00
Cyclacel Pharmaceuticals (CYCC) $0.025B 0.00
Clene (CLNN) United States $0.025B 0.00
CalciMedica (CALC) United States $0.024B 0.00
Vor Biopharma (VOR) $0.024B 0.00
Advanced Biomed (ADVB) United States $0.024B 0.00
ABVC BioPharma (ABVC) United States $0.024B 0.00
Curis (CRIS) United States $0.024B 0.00
Lisata Therapeutics (LSTA) United States $0.023B 0.00
Q32 Bio (QTTB) United States $0.023B 0.00
BioAtla (BCAB) United States $0.023B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.023B 0.00
Ovid Therapeutics (OVID) United States $0.021B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.021B 0.00
X4 Pharmaceuticals (XFOR) United States $0.020B 0.00
HOOKIPA Pharma (HOOK) United States $0.020B 0.00
Longeveron (LGVN) United States $0.020B 0.00
Lexaria Bioscience (LEXX) Canada $0.018B 0.00
Elevation Oncology (ELEV) United States $0.018B 0.00
Cingulate (CING) United States $0.017B 0.00
SAB Biotherapeutics (SABS) United States $0.017B 0.00
Promis Neurosciences (PMN) Canada $0.017B 0.00
Beyond Air (XAIR) United States $0.016B 0.00
GeoVax Labs (GOVX) United States $0.016B 0.00
Gelteq (GELS) Australia $0.016B 0.00
Leap Therapeutics (LPTX) United States $0.016B 0.00
Cognition Therapeutics (CGTX) United States $0.015B 0.00
Abpro Holdings (ABP) United States $0.014B 0.00
Edesa Biotech (EDSA) Canada $0.014B 0.00
IN8bio (INAB) United States $0.014B 0.00
NextCure (NXTC) United States $0.014B 0.00
Synlogic (SYBX) United States $0.013B 0.00
Allarity Therapeutics (ALLR) United States $0.013B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.013B 0.00
MetaVia (MTVA) United States $0.013B 0.00
Rallybio (RLYB) United States $0.013B 0.00
Biorestorative Therapies (BRTX) United States $0.013B 0.00
IBio (IBIO) United States $0.013B 0.00
Moleculin Biotech (MBRX) United States $0.013B 0.00
Equillium (EQ) United States $0.012B 0.00
Bionano Genomics (BNGO) United States $0.012B 0.00
Neuphoria Therapeutics (NEUP) Australia $0.012B 0.00
BRIACELL THERAP (BCTX) Canada $0.012B 0.00
Bolt Biotherapeutics (BOLT) United States $0.012B 0.00
UNITY Biotechnology (UBX) United States $0.012B 0.00
HCW Biologics (HCWB) United States $0.012B 0.00
Hoth Therapeutics (HOTH) United States $0.011B 0.00
Aytu BioPharma (AYTU) United States $0.011B 0.00
BioCardia (BCDA) United States $0.011B 0.00
Athira Pharma (ATHA) United States $0.011B 0.00
COSCIENS Biopharma (CSCI) Canada $0.011B 0.00
IMMURON (IMRN) Australia $0.011B 0.00
Dogwood Therapeutics (DWTX) United States $0.010B 0.00
LakeShore Biopharma (LSB) China $0.010B 0.00
Aprea Therapeutics (APRE) United States $0.010B 0.00
BioAffinity Technologies (BIAF) United States $0.009B 0.00
GENPREX (GNPX) United States $0.009B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.009B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.009B 0.00
Cyclerion Therapeutics (CYCN) United States $0.009B 0.00
Portage Biotech (PRTG) $0.009B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.008B 0.00
Sensei Biotherapeutics (SNSE) United States $0.008B 0.00
Turnstone Biologics (TSBX) United States $0.007B 0.00
BioXcel Therapeutics (BTAI) United States $0.007B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.007B 0.00
Intensity Therapeutics (INTS) United States $0.007B 0.00
Avalon GloboCare (ALBT) United States $0.007B 0.00
Pasithea Therapeutics (KTTA) United States $0.007B 0.00
GT Biopharma (GTBP) United States $0.007B 0.00
Apollomics (APLM) United States $0.007B 0.00
Mainz Biomed (MYNZ) Germany $0.007B 0.00
Polyrizon (PLRZ) Israel $0.007B 0.00
Sunshine Biopharma (SBFM) United States $0.007B 0.00
Arcadia Biosciences (RKDA) United States $0.006B 0.00
Soligenix (SNGX) United States $0.006B 0.00
Evogene (EVGN) Israel $0.006B 0.00
Jade Biosciences (JBIO) United States $0.006B 0.00
180 Life Sciences (ATNF) United States $0.006B 0.00
Mustang Bio (MBIO) United States $0.006B 0.00
CNS Pharmaceuticals (CNSP) United States $0.006B 0.00
Biofrontera (BFRI) United States $0.006B 0.00
Adial Pharmaceuticals (ADIL) United States $0.005B 0.00
Eyenovia (EYEN) United States $0.005B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.005B 0.00
Ensysce Biosciences (ENSC) United States $0.005B 0.00
Onconetix (ONCO) United States $0.005B 0.00
Dermata Therapeutics (DRMA) United States $0.005B 0.00
Alzamend Neuro (ALZN) United States $0.004B 0.00
Galecto (GLTO) Denmark $0.004B 0.00
Titan Pharmaceuticals (TTNP) United States $0.004B 0.00
Tharimmune (THAR) United States $0.004B 0.00
Novogen (KZIA) Australia $0.004B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.004B 0.00
AquaBounty Technologies (AQB) United States $0.004B 0.00
VivoSim Labs (VIVS) United States $0.004B 0.00
Synaptogenix (SNPX) United States $0.003B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.003B 0.00
Artelo Biosciences (ARTL) United States $0.003B 0.00
Palisade Bio (PALI) United States $0.003B 0.00
Purple Biotech (PPBT) Israel $0.003B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.003B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.003B 0.00
Enveric Biosciences (ENVB) United States $0.003B 0.00
Psyence Biomedical (PBM) Canada $0.003B 0.00
GRI Bio (GRI) United States $0.003B 0.00
Affimed (AFMD) Germany $0.003B 0.00
Windtree Therapeutics (WINT) United States $0.003B 0.00
Bone Biologics (BBLG) United States $0.003B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.003B 0.00
Atrinsic (PTIX) United States $0.002B 0.00
Silo Pharma (SILO) United States $0.002B 0.00
Entero Therapeutics (ENTO) United States $0.002B 0.00
Aptevo Therapeutics (APVO) United States $0.002B 0.00
Revelation Biosciences (REVB) United States $0.001B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
Capstone Therapeutics (CAPS) United States $0.000B 0.00
NuCana (NCNA) United Kingdom $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00
Cocrystal Pharma (COCP) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.000B 0.00
Galapagos (GLPG) Belgium $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pulmatrix (PULM) United States $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00